8-KEarnings & ResultsExhibits & Filings

Merck & Co., Inc. 8-K Report, Financial Results (Jul 27, 2012)

Filed July 27, 2012For Securities:MRK

Summary

This Form 8-K filing by Merck & Co., Inc. (MRK) on July 27, 2012, primarily serves to announce the company's financial results for the second quarter of 2012. The report incorporates by reference a press release and supplemental financial information, providing investors with key details on the company's performance during the period. This filing is crucial for understanding Merck's operational and financial health as of the second quarter of 2012. Investors should pay close attention to the details within the referenced press release and supplemental information for a comprehensive understanding of Merck's Q2 2012 performance. While the 8-K itself does not contain the detailed financial figures, it directs readers to the primary sources of this information, which are essential for assessing the company's financial condition, revenue generation, profitability, and any significant operational developments that may have impacted these results.

Key Highlights

  • 1Merck & Co., Inc. filed a Form 8-K on July 27, 2012.
  • 2The filing pertains to the company's financial results for the second quarter of 2012.
  • 3Key financial information is provided through an incorporated press release (Exhibit 99.1).
  • 4Additional supplemental financial information not in the press release is also incorporated (Exhibit 99.2).
  • 5The report highlights the company's operations and financial condition as of Q2 2012.
  • 6This filing is an update on Merck's financial performance, not a material event outside of routine financial reporting.
  • 7The information provided is furnished under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits).

Frequently Asked Questions

The main purpose of this Form 8-K filing is to report Merck & Co., Inc.'s financial results and condition for the second quarter of 2012. It incorporates by reference a press release and supplemental information containing these details.

The specific financial details for Merck's second quarter of 2012 are contained within the press release (Exhibit 99.1) and the supplemental information (Exhibit 99.2) that are incorporated by reference into this 8-K filing. Investors would need to access these exhibits for the complete financial data.

This particular 8-K filing, filed on July 27, 2012, primarily focuses on reporting routine quarterly financial results. It does not appear to announce any significant new business events, mergers, acquisitions, or other material changes outside of the company's ongoing financial performance.

The statement indicates that the information provided under Item 2.02 is being furnished to the SEC and is not considered 'filed' for the purposes of Section 18 of the Securities Exchange Act of 1934. This means the information does not automatically become subject to the liabilities of that section, nor is it automatically incorporated into Merck's other SEC filings unless specifically referenced.